Cargando…

Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study

BACKGROUND: This longitudinal study described Cytomegalovirus (CMV) DNA, Epstein-Barr (EBV) DNA and human herpesvirus 8 (HHV-8) DNA asymptomatic salivary shedding in HIV-positive men who have sex with men (MSM). We aimed to 1-analyze frequency and persistence of herpesvirus shedding, 2-correlate her...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso, Monica, Andreis, Samantha, Scaggiante, Renzo, Franchin, Elisa, Zago, Daniela, Biasolo, Maria Angela, Del Vecchio, Claudia, Mengoli, Carlo, Sarmati, Loredana, Andreoni, Massimo, Palù, Giorgio, Parisi, Saverio Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300014/
https://www.ncbi.nlm.nih.gov/pubmed/30567494
http://dx.doi.org/10.1186/s12879-018-3591-x
_version_ 1783381608025292800
author Basso, Monica
Andreis, Samantha
Scaggiante, Renzo
Franchin, Elisa
Zago, Daniela
Biasolo, Maria Angela
Del Vecchio, Claudia
Mengoli, Carlo
Sarmati, Loredana
Andreoni, Massimo
Palù, Giorgio
Parisi, Saverio Giuseppe
author_facet Basso, Monica
Andreis, Samantha
Scaggiante, Renzo
Franchin, Elisa
Zago, Daniela
Biasolo, Maria Angela
Del Vecchio, Claudia
Mengoli, Carlo
Sarmati, Loredana
Andreoni, Massimo
Palù, Giorgio
Parisi, Saverio Giuseppe
author_sort Basso, Monica
collection PubMed
description BACKGROUND: This longitudinal study described Cytomegalovirus (CMV) DNA, Epstein-Barr (EBV) DNA and human herpesvirus 8 (HHV-8) DNA asymptomatic salivary shedding in HIV-positive men who have sex with men (MSM). We aimed to 1-analyze frequency and persistence of herpesvirus shedding, 2-correlate herpesvirus positivity and HIV viroimmunological parameters and 3-assess the association between HIV-RNA suppression and herpesvirus replication. METHODS: Herpesvirus DNA was tested with an in-house real-time PCR in 2 salivary samples obtained at T0 and T1 (24 months after T0). HIV-RNA was evaluated in the 24 months prior to T0 and in the 24 months prior to T1; MSM were classified as successfully suppressed patients (SSPs), viremic patients (VPs) and partially suppressed patients (PSPs). EBV DNA load was classified as low viral load (EBV-LVL, value ≤10,000 copies/ml) and as high viral load (EBV-HVL,> 10,000 copies/ml). Mann-Whitney U test tested the difference of the median between groups of patients. Chi-squared test and Fisher’s exact test compared categorical variables according to the frequencies. Kruskal-Wallis test compared continuous data distributions between levels of categorical variables. RESULTS: Ninety-two patients (median CD4+ count 575 cells/mm3, median nadir 330 CD4+ cells/mm3) were included: 40 SSPs,33 VPs and 19 PSPs. The more frequently single virus detected was EBV, both at T0 and at T1 (in 67.5 and 70% of SSPs, in 84.8 and 81.8% of VPs and in 68.4 and 73.7% of SPSs) and the most frequently multiple positivity detected was EBV + HHV-8. At T1, the percentage of CMV positivity was higher in VPs than in SSPs (36.4% vs 5%, p < 0.001), the combined shedding of HHV-8, CMV and EBV was present only in VPs (15.1%, p = 0.01 respect to SSPs) and no VPs confirmed the absence of shedding found at T0 (vs 17.5% of SSPs, p = 0.01). EBV-HVL was more frequent in VPs than in SSPs: 78.6% at T0 (p = 0.03) and 88.9% at T1 (p = 0.01). CONCLUSIONS: The relationship between uncontrolled plasma HIV viremia and CMV, EBV, and HHV-8 shedding is multifaceted, as demonstrated by the focused association with EBV DNA load and not with its frequency and by the persistent combined detection of two oncogenic viruses as EBV and HHV-8 regardless of HIV virological control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3591-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6300014
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63000142018-12-20 Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study Basso, Monica Andreis, Samantha Scaggiante, Renzo Franchin, Elisa Zago, Daniela Biasolo, Maria Angela Del Vecchio, Claudia Mengoli, Carlo Sarmati, Loredana Andreoni, Massimo Palù, Giorgio Parisi, Saverio Giuseppe BMC Infect Dis Research Article BACKGROUND: This longitudinal study described Cytomegalovirus (CMV) DNA, Epstein-Barr (EBV) DNA and human herpesvirus 8 (HHV-8) DNA asymptomatic salivary shedding in HIV-positive men who have sex with men (MSM). We aimed to 1-analyze frequency and persistence of herpesvirus shedding, 2-correlate herpesvirus positivity and HIV viroimmunological parameters and 3-assess the association between HIV-RNA suppression and herpesvirus replication. METHODS: Herpesvirus DNA was tested with an in-house real-time PCR in 2 salivary samples obtained at T0 and T1 (24 months after T0). HIV-RNA was evaluated in the 24 months prior to T0 and in the 24 months prior to T1; MSM were classified as successfully suppressed patients (SSPs), viremic patients (VPs) and partially suppressed patients (PSPs). EBV DNA load was classified as low viral load (EBV-LVL, value ≤10,000 copies/ml) and as high viral load (EBV-HVL,> 10,000 copies/ml). Mann-Whitney U test tested the difference of the median between groups of patients. Chi-squared test and Fisher’s exact test compared categorical variables according to the frequencies. Kruskal-Wallis test compared continuous data distributions between levels of categorical variables. RESULTS: Ninety-two patients (median CD4+ count 575 cells/mm3, median nadir 330 CD4+ cells/mm3) were included: 40 SSPs,33 VPs and 19 PSPs. The more frequently single virus detected was EBV, both at T0 and at T1 (in 67.5 and 70% of SSPs, in 84.8 and 81.8% of VPs and in 68.4 and 73.7% of SPSs) and the most frequently multiple positivity detected was EBV + HHV-8. At T1, the percentage of CMV positivity was higher in VPs than in SSPs (36.4% vs 5%, p < 0.001), the combined shedding of HHV-8, CMV and EBV was present only in VPs (15.1%, p = 0.01 respect to SSPs) and no VPs confirmed the absence of shedding found at T0 (vs 17.5% of SSPs, p = 0.01). EBV-HVL was more frequent in VPs than in SSPs: 78.6% at T0 (p = 0.03) and 88.9% at T1 (p = 0.01). CONCLUSIONS: The relationship between uncontrolled plasma HIV viremia and CMV, EBV, and HHV-8 shedding is multifaceted, as demonstrated by the focused association with EBV DNA load and not with its frequency and by the persistent combined detection of two oncogenic viruses as EBV and HHV-8 regardless of HIV virological control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3591-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-19 /pmc/articles/PMC6300014/ /pubmed/30567494 http://dx.doi.org/10.1186/s12879-018-3591-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Basso, Monica
Andreis, Samantha
Scaggiante, Renzo
Franchin, Elisa
Zago, Daniela
Biasolo, Maria Angela
Del Vecchio, Claudia
Mengoli, Carlo
Sarmati, Loredana
Andreoni, Massimo
Palù, Giorgio
Parisi, Saverio Giuseppe
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title_full Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title_fullStr Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title_full_unstemmed Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title_short Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
title_sort cytomegalovirus, epstein-barr virus and human herpesvirus 8 salivary shedding in hiv positive men who have sex with men with controlled and uncontrolled plasma hiv viremia: a 24-month longitudinal study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300014/
https://www.ncbi.nlm.nih.gov/pubmed/30567494
http://dx.doi.org/10.1186/s12879-018-3591-x
work_keys_str_mv AT bassomonica cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT andreissamantha cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT scaggianterenzo cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT franchinelisa cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT zagodaniela cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT biasolomariaangela cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT delvecchioclaudia cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT mengolicarlo cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT sarmatiloredana cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT andreonimassimo cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT palugiorgio cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy
AT parisisaveriogiuseppe cytomegalovirusepsteinbarrvirusandhumanherpesvirus8salivarysheddinginhivpositivemenwhohavesexwithmenwithcontrolledanduncontrolledplasmahivviremiaa24monthlongitudinalstudy